Short interest in Ligand Pharmaceuticals Inc (NASDAQ:LGND) decreased during the last reporting period, falling from 831.45K to 785.70K. This put 5.75% of the company's publicly available shares short.

Short interest for Ligand Pharmaceuticals gives investors a sense of the degree to which investors are betting on the decline of Ligand Pharmaceuticals's stock. Short interest data is updated every two weeks.

Based on the recent average volume of 112.91K shares traded per day, it would take 6.96 day(s) for holders of this short interest to close out their positions without sending the stock sharply higher.